Talc or Minocycline Pleurodesis May Aid managing malignant pleural effusion Management in Lung Cancer with ILD: Study
Advertisement
Researchers have found in a new study that Pleurodesis using talc or minocycline had potential as a treatment option for managing malignant pleural effusion (MPE) in patients with lung cancer complicated by interstitial lung disease (ILD).
What is known and what is new?
• The efficacy rate of pleurodesis with talc and minocycline is about 70%. Acute respiratory distress syndrome (ARDS) after pleurodesis with talc is a concern. The partially expanded lung before pleurodesis is known as the predictor of pleurodesis failure. The efficacy and safety of pleurodesis against MPE complicated with ILD have not been elucidated.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.